Many people in Newport Beach and Orange County, California struggle with chronic fatigue, pain, brain fog, and nervous system symptoms that are difficult to explain with standard testing. These symptoms are commonly seen in conditions such as Ehlers Danlos Syndrome, Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS), Long COVID, and dysautonomia.

Emerging research across all of these conditions points to a shared issue deep inside the body’s cells: mitochondrial dysfunction.

This article explains what that means, why it matters, and how light based therapies such as red light therapy and advanced Class 4 MLS laser may support mitochondrial function as part of a comprehensive care plan.


What Are Mitochondria and Why Do They Matter?

Mitochondria are small structures inside every cell that act like power plants. Their job is to produce ATP, the energy your body uses to think, move, heal, and regulate automatic functions like heart rate, digestion, and temperature control.

When mitochondria are not working efficiently, cells cannot produce enough energy. This can lead to:

  • Persistent fatigue
  • Muscle pain and weakness
  • Poor exercise tolerance
  • Brain fog
  • Autonomic symptoms such as dizziness, palpitations, or blood pressure swings

In many chronic conditions, the problem is not a lack of effort or conditioning. It is that the cells simply cannot keep up with energy demand.


Conditions Commonly Linked to Mitochondrial Dysfunction

Ehlers Danlos Syndrome and Dysautonomia

In Ehlers Danlos Syndrome, particularly hypermobile and vascular subtypes, research shows abnormalities in cellular energy metabolism and increased oxidative stress. These mitochondrial challenges help explain why many patients experience:

  • Chronic fatigue
  • Muscle and joint pain
  • Difficulty tolerating physical activity
  • Dysautonomia, including POTS and temperature regulation issues


Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)

Myalgic Encephalomyelitis/Chronic Fatigue Syndrome is a serious condition marked by profound fatigue that does not improve with rest.

In ME/CFS, studies consistently show:

  • Reduced ATP production
  • Poor ability to increase energy output when stressed
  • Abnormal mitochondrial enzyme function
  • A biological basis for post exertional symptom worsening

This helps explain why even small amounts of physical or mental activity can trigger prolonged symptom flares.


Long COVID

Long COVID often includes fatigue, brain fog, exercise intolerance, and autonomic symptoms long after the initial infection has resolved.

Research suggests that viral illness can:

  • Disrupt mitochondrial membranes
  • Increase oxidative stress
  • Impair normal energy metabolism
  • Lead to ongoing inflammation

Together, these changes place long term strain on cellular energy systems.


How Light Therapy Supports Mitochondrial Function

Light based therapies, often referred to as photobiomodulation, use specific wavelengths of red and near infrared light to interact directly with mitochondria.


Core Biological Effects

When therapeutic light reaches cells, it is absorbed by enzymes inside mitochondria that are directly involved in energy production. This interaction can lead to:

  • Improved ATP production
  • More efficient mitochondrial respiration
  • Better cellular stress tolerance
  • Activation of protective and anti inflammatory pathways


Key Mechanisms of Action

To clarify how this works at a cellular level, research suggests several key mechanisms:

  • Light absorption by cytochrome c oxidase in the mitochondrial respiratory chain
  • Improved electron transport and ATP synthesis
    Modulation of nitric oxide signaling that can block energy production
  • Activation of signaling pathways involved in cell repair and antioxidant defense
  • Improved mitochondrial membrane stability and function

These effects are most noticeable in cells that are under stress or functioning poorly, which is why light therapy tends to have minimal effect on healthy tissue but greater impact in chronic illness.


Red Light Therapy and Advanced Class 4 MLS Laser

Red Light Therapy

Red light therapy typically uses wavelengths in the red spectrum to support superficial tissues and cellular signaling. It is commonly used for skin health, inflammation modulation, and surface level tissue support.

Benefits may include:

  • Reduced inflammation
  • Improved cellular signaling
  • Support of mitochondrial function in superficial tissues

Advanced Class 4 MLS Laser

Class 4 MLS laser represents a more advanced form of photobiomodulation. It uses synchronized dual wavelengths in the near infrared range that allow deeper tissue penetration and higher power delivery under controlled medical protocols.

Research shows that these wavelengths:

  • Reach deeper muscle and nerve tissue
  • Stimulate mitochondrial respiratory complexes involved in ATP production
  • Improve mitochondrial membrane potential
  • Support both anti inflammatory and bioenergetic responses


The synchronized delivery of continuous and pulsed wavelengths allows for:

  • Energy support at the cellular level
  • Reduction in tissue swelling
  • Improved neuromuscular and autonomic regulation

Because of this depth and power, Class 4 MLS laser is often used in clinical settings where fatigue, nervous system dysregulation, and musculoskeletal pain overlap.


What to Expect From Treatment

Light therapy is:

  • Non-invasive
  • Generally well tolerated
  • Associated with minimal side effects such as mild temporary skin redness
  • Most effective when performed consistently over multiple sessions

Treatment plans should always be individualized based on symptoms, tolerance, and response.


A Supportive Therapy, Not a Stand Alone Solution

While light therapy can support mitochondrial function, it works best as part of a broader plan that may include:

  • Activity pacing and energy conservation
  • Nutritional strategies that support mitochondrial health
  • Targeted physical therapy
  • Autonomic nervous system support
  • Other physician guided treatments


Final Thoughts for Patients in Orange County

For patients in Newport Beach and Orange County dealing with fatigue, pain, dysautonomia, or brain fog, mitochondrial dysfunction provides a unifying biological explanation that is often overlooked.

Light based therapies, including red light therapy and advanced Class 4 MLS laser, offer a non invasive way to support cellular energy production and nervous system regulation. While research is still evolving, the biological foundation is strong and continues to grow.

If you are exploring options beyond symptom suppression, it may be worth discussing whether light therapy fits into your overall care strategy with a clinician experienced in complex chronic conditions.

References
  1. Photobiomodulation CME Part I: Overview and Mechanism of Action.
    Maghfour J, Ozog DM, Mineroff J, et al. Journal of the American Academy of Dermatology. 2024;91(5):793-802. doi:10.1016/j.jaad.2023.10.073.
  2. The Application of Light Emitting Diode (LED) in Cosmetic Dermatology.
    Guo Z, Yuan K. Photodermatology, Photoimmunology & Photomedicine. 2025;41(5):e70041. doi:10.1111/phpp.70041.
  3. Inhibitory Effect of 660-Nm LED on Melanin Synthesis in In vitro and In vivo.
    Oh CT, Kwon TR, Choi EJ, et al. Photodermatology, Photoimmunology & Photomedicine. 2017;33(1):49-57. doi:10.1111/phpp.12276.
  4. Efficacy and Safety of 570/590 Nm Yellow Light Combined With Red Light and Infrared LED in Treating Facial Skin Photoaging: A Single-Center, Randomized Controlled, Exploratory Study.
    Yi S, Ding J, Li X, et al. Lasers in Medical Science. 2025;40(1):435. doi:10.1007/s10103-025-04659-6.
  5. 590 Nm LED Irradiation Improved Erythema Through Inhibiting Angiogenesis of Human Microvascular Endothelial Cells and Ameliorated Pigmentation in Melasma.
    Dai X, Jin S, Xuan Y, et al. Cells. 2022;11(24):3949. doi:10.3390/cells11243949.
  6. Utilization of Light-Emitting Diodes for Skin Therapy: Systematic Review and Meta-Analysis.
    Ngoc LTN, Moon JY, Lee YC. Photodermatology, Photoimmunology & Photomedicine. 2023;
    39(4):303-317. doi:10.1111/phpp.12841.
  7. Cutaneous Interaction With Visible Light: What Do We Know?.
    Cohen L, Brodsky MA, Zubair R, et al. Journal of the American Academy of Dermatology. 2023;
    89(3):560-568. doi:10.1016/j.jaad.2020.03.115.
  8. Position Statement:Red Light Therapy at Tanning Salons.
    American Academy of Dermatology (2023)
  9. Insights Into the Complex Biological Network Underlying Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
    Dudova D, Bozhkova M, Petrov S, et al. International Journal of Molecular Sciences. 2025;27(1):268. doi:10.3390/ijms27010268.
  10. Proposed Mechanisms of Photobiomodulation or Low-Level Light Therapy.
    de Freitas LF, Hamblin MR. IEEE Journal of Selected Topics in Quantum Electronics : A Publication of the IEEE Lasers and Electro-Optics Society. 2016 May-Jun;
    22(3):7000417. doi:10.1109/JSTQE.2016.2561201.
  11. Combination of Common mtDNA Variants Results in Mitochondrial Dysfunction and a Connective Tissue Dysregulation.
    Schaefer PM, Scherer Alves L, Lvova M, et al. Proceedings of the National Academy of Sciences of the United States of America. 2022;119(45):e2212417119. doi:10.1073/pnas.2212417119.
  12. Multi-OMICs Analysis on Tridimensional Fibroblast Spheroids to Model Vascular Ehlers-Danlos Syndrome Pathogenesis.
    Micale L, Di Muro E, De Cegli R, et al. Biochimica Et Biophysica Acta. Molecular Basis of Disease. 2025;1871(6):167896. doi:10.1016/j.bbadis
    .2025.167896.
  13. Biological Insights in the Pathogenesis of Hypermobile Ehlers-Danlos Syndrome From Proteome Profiling of Patients’ Dermal Myofibroblasts.
    Chiarelli N, Zoppi N, Ritelli M, et al. Biochimica Et Biophysica Acta. Molecular Basis of Disease. 2021;
    1867(4):166051. doi:10.1016/j.bbadis.2020.166051.
  14. Cellular and Molecular Mechanisms in the Pathogenesis of Classical, Vascular, and Hypermobile Ehlers‒Danlos Syndromes.
    Chiarelli N, Ritelli M, Zoppi N, Colombi M. Genes. 2019;10(8):E609. doi:10.3390/genes10080609.
  15. The Effect of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) Severity on Cellular Bioenergetic Function.
    Tomas C, Elson JL, Strassheim V, Newton JL, Walker M. PloS One. 2020;15(4):e0231136. doi:10.1371/journal.pone.0231136.
  16. Photobiomodulation-Underlying Mechanism and Clinical Applications.
    Dompe C, Moncrieff L, Matys J, et al. Journal of Clinical Medicine. 2020;9(6):E1724. doi:10.3390/jcm9061724.
  17. Neurological and Psychological Applications of Transcranial Lasers and LEDs.
    Rojas JC, Gonzalez-Lima F. Biochemical Pharmacology. 2013;86(4):447-57. doi:10.1016/j.bcp.2013.06.012.
  18. An Isolated Complex v Inefficiency and Dysregulated Mitochondrial Function in Immortalized Lymphocytes From ME/CFS Patients.
    Missailidis D, Annesley SJ, Allan CY, et al. International Journal of Molecular Sciences. 2020;21(3):E1074. doi:10.3390/ijms21031074.
  19. Differential Effects of 808-Nm Light on Electron Transport Chain Enzymes in Isolated Mitochondria: Implications for Photobiomodulation Initiation.
    Pope NJ, Denton ML. Mitochondrion. 2023;68:15-24. doi:10.1016/j.mito.2022.11.002.
  20. Low-Level Laser Therapy Activates NF-kB via Generation of Reactive Oxygen Species in Mouse Embryonic Fibroblasts.
    Chen AC, Arany PR, Huang YY, et al. PloS One. 2011;6(7):e22453. doi:10.1371/journal.pone.0022453.
  21. Photobiomodulation and Oxidative Stress: 980 nm Diode Laser Light Regulates Mitochondrial Activity and Reactive Oxygen Species Production.
    Amaroli A, Pasquale C, Zekiy A, et al. Oxidative Medicine and Cellular Longevity. 2021;2021:6626286. doi:10.1155/2021/6626286.
  22. High-Power Laser Therapy Modulates Mitochondrial Function and Redox Balance Without Cytotoxicity: An in Vitro Study in BV-2 Microglial Cells.
    Dias LB, De Marchi T, Visentin APV, et al. Antioxidants (Basel, Switzerland). 2025;14(10):1243. doi:10.3390/antiox14101243.
  23. Effects of Photobiomodulation on Mitochondria of Brain, Muscle, and C6 Astroglioma Cells.
    Silveira PCL, Ferreira GK, Zaccaron RP, et al. Medical Engineering & Physics. 2019;71:108-113. doi:10.1016/j.medengphy.2019.05.008.
  24. Photobiomodulation Therapy for Enhanced Wound and Scar Healing: Visual and Statistical Evaluation.
    Shurrab K, Wael Aoida N. Lasers in Medical Science. 2025;40(1):334. doi:10.1007/s10103-025-04587-5.
  25. Possible Pathogenesis and Prevention of Long COVID: SARS-CoV-2-Induced Mitochondrial Disorder.
    Chen TH, Chang CJ, Hung PH. International Journal of Molecular Sciences. 2023;24(9):8034. doi:10.3390/ijms24098034.
  26. Persistent Monocytic Bioenergetic Impairment and Mitochondrial DNA Damage in PASC Patients With Cardiovascular Complications.
    Semo D, Shomanova Z, Sindermann J, et al. International Journal of Molecular Sciences. 2025;26(10):4562. doi:10.3390/ijms26104562.
  27. Mitochondrial Reactive Oxygen Species: A Unifying Mechanism in Long COVID and Spike Protein-Associated Injury: A Narrative Review.
    Lee E, Ozigbo AA, Varon J, et al. Biomolecules. 2025;15(9):1339. doi:10.3390/biom15091339.
  28. Mitochondrial Dysfunction in Long COVID: Mechanisms, Consequences, and Potential Therapeutic Approaches.
    Molnar T, Lehoczki A, Fekete M, et al. GeroScience. 2024;46(5):5267-5286. doi:10.1007/s11357-024-01165-5.